UBE2T activators represent a category of chemicals that selectively enhance the function of UBE2T, which is an E2 ubiquitin-conjugating enzyme. UBE2T plays an integral role in the ubiquitin-proteasome system, particularly in the fanconi anemia (FA) pathway where it is involved in the repair of DNA interstrand crosslinks. The enzyme achieves this by working in concert with an E3 ubiquitin ligase to transfer ubiquitin from its active site cysteine to a lysine residue on a target protein, which is a key step in the DNA damage response.
Direct activators of UBE2T likely interact with the enzyme to increase its intrinsic ubiquitin-conjugating activity or its interaction with E3 ligases or specific substrates. These interactions could involve binding to the active site and stabilizing the UBE2T-ubiquitin thioester intermediate, thereby enhancing the enzyme's ability to ubiquitinate target substrates. They could also stabilize the interaction between UBE2T and its E3 ligase partners, promoting the transfer of ubiquitin to substrates involved in DNA repair. Indirect UBE2T activators may alter the enzyme's activity by modulating the cellular environment or signaling pathways that affect its function. This could involve upregulating the expression of UBE2T, affecting the stability of the protein, or influencing post-translational modifications that regulate enzyme activity. For instance, phosphorylation of UBE2T at specific residues might increase its catalytic turnover or its affinity for E3 ligases or ubiquitin.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
An antibiotic that cross-links DNA. Activates the FA pathway in response to interstrand cross-links. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
A chemotherapy drug that forms DNA cross-links. Initiates the FA pathway, indirectly activating UBE2T. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Inhibits DNA synthesis. It can result in DNA damage leading to FA pathway activation. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits DNA topoisomerase I, leading to DNA damage and possible FA pathway activation. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Targets DNA topoisomerase II, leading to DNA strand breaks and the potential activation of the FA pathway. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
PARP inhibitor. Causes DNA damage by trapping PARP. This damage might lead to FA pathway and UBE2T activation. | ||||||
Talazoparib | 1207456-01-6 | sc-507440 | 10 mg | $795.00 | ||
Another PARP inhibitor. Like Olaparib, it can result in DNA damage and potential FA pathway activation. | ||||||
Bleomycin Sulfate | 9041-93-4 | sc-200134 sc-200134A sc-200134B sc-200134C | 10 mg 50 mg 100 mg 500 mg | $210.00 $624.00 $1040.00 $2913.00 | 38 | |
Induces DNA breaks. The resultant DNA damage can activate the FA pathway and UBE2T. | ||||||
Aclacinomycin A | 57576-44-0 | sc-200160 | 5 mg | $132.00 | 10 | |
Intercalates DNA and could potentially activate the FA pathway indirectly. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Inhibits DNA polymerase, leading to stalled replication forks, potentially activating the FA pathw | ||||||